BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 33808755)

  • 1. Immunization with Epstein-Barr Virus Core Fusion Machinery Envelope Proteins Elicit High Titers of Neutralizing Activities and Protect Humanized Mice from Lethal Dose EBV Challenge.
    Cui X; Cao Z; Ishikawa Y; Cui S; Imadome KI; Snapper CM
    Vaccines (Basel); 2021 Mar; 9(3):. PubMed ID: 33808755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rabbits immunized with Epstein-Barr virus gH/gL or gB recombinant proteins elicit higher serum virus neutralizing activity than gp350.
    Cui X; Cao Z; Chen Q; Arjunaraja S; Snow AL; Snapper CM
    Vaccine; 2016 Jul; 34(34):4050-5. PubMed ID: 27291087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases.
    Cui X; Snapper CM
    Front Immunol; 2021; 12():734471. PubMed ID: 34691042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization of Rabbits with Recombinant Human Cytomegalovirus Trimeric versus Monomeric gH/gL Protein Elicits Markedly Higher Titers of Antibody and Neutralization Activity.
    Cui X; Cao Z; Wang S; Flora M; Adler SP; McVoy MA; Snapper CM
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with Human Cytomegalovirus Core Fusion Machinery and Accessory Envelope Proteins Elicit Strong Synergistic Neutralizing Activities.
    Cui X; Cao Z; Wang S; Adler SP; McVoy MA; Snapper CM
    Vaccines (Basel); 2020 Apr; 8(2):. PubMed ID: 32294946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Epstein-Barr virus-like particles incorporating gH/gL-EBNA1 or gB-LMP2 induce high neutralizing antibody titers and EBV-specific T-cell responses in immunized mice.
    Perez EM; Foley J; Tison T; Silva R; Ogembo JG
    Oncotarget; 2017 Mar; 8(12):19255-19273. PubMed ID: 27926486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with Components of the Viral Fusion Apparatus Elicits Antibodies That Neutralize Epstein-Barr Virus in B Cells and Epithelial Cells.
    Bu W; Joyce MG; Nguyen H; Banh DV; Aguilar F; Tariq Z; Yap ML; Tsujimura Y; Gillespie RA; Tsybovsky Y; Andrews SF; Narpala SR; McDermott AB; Rossmann MG; Yasutomi Y; Nabel GJ; Kanekiyo M; Cohen JI
    Immunity; 2019 May; 50(5):1305-1316.e6. PubMed ID: 30979688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A bivalent Epstein-Barr virus vaccine induces neutralizing antibodies that block infection and confer immunity in humanized mice.
    Wei CJ; Bu W; Nguyen LA; Batchelor JD; Kim J; Pittaluga S; Fuller JR; Nguyen H; Chou TH; Cohen JI; Nabel GJ
    Sci Transl Med; 2022 May; 14(643):eabf3685. PubMed ID: 35507671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus gH/gL has multiple sites of vulnerability for virus neutralization and fusion inhibition.
    Chen WH; Kim J; Bu W; Board NL; Tsybovsky Y; Wang Y; Hostal A; Andrews SF; Gillespie RA; Choe M; Stephens T; Yang ES; Pegu A; Peterson CE; Fisher BE; Mascola JR; Pittaluga S; McDermott AB; Kanekiyo M; Joyce MG; Cohen JI
    Immunity; 2022 Nov; 55(11):2135-2148.e6. PubMed ID: 36306784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr Virus Fusion with Epithelial Cells Triggered by gB Is Restricted by a gL Glycosylation Site.
    Möhl BS; Chen J; Park SJ; Jardetzky TS; Longnecker R
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Pentavalent Epstein-Barr Virus-Like Particle Vaccine Elicits High Titers of Neutralizing Antibodies against Epstein-Barr Virus Infection in Immunized Rabbits.
    Escalante GM; Foley J; Mutsvunguma LZ; Rodriguez E; Mulama DH; Muniraju M; Ye P; Barasa AK; Ogembo JG
    Vaccines (Basel); 2020 Apr; 8(2):. PubMed ID: 32268575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with a self-assembling nanoparticle vaccine displaying EBV gH/gL protects humanized mice against lethal viral challenge.
    Malhi H; Homad LJ; Wan YH; Poudel B; Fiala B; Borst AJ; Wang JY; Walkey C; Price J; Wall A; Singh S; Moodie Z; Carter L; Handa S; Correnti CE; Stoddard BL; Veesler D; Pancera M; Olson J; King NP; McGuire AT
    Cell Rep Med; 2022 Jun; 3(6):100658. PubMed ID: 35705092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Cytoplasmic Tail Domain of Epstein-Barr Virus gH Regulates Membrane Fusion Activity through Altering gH Binding to gp42 and Epithelial Cell Attachment.
    Chen J; Jardetzky TS; Longnecker R
    mBio; 2016 Nov; 7(6):. PubMed ID: 27935841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vesicular Stomatitis Virus-Based Epstein-Barr Virus Vaccines Elicit Strong Protective Immune Responses.
    Kong XW; Zhang X; Bu GL; Xu HQ; Kang YF; Sun C; Zhu QY; Ma RB; Liu Z; Zeng YX; Zeng MS; Hu ZL
    J Virol; 2022 May; 96(9):e0033622. PubMed ID: 35404082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel vaccine candidate based on chimeric virus-like particle displaying multiple conserved epitope peptides induced neutralizing antibodies against EBV infection.
    Zhang X; Zhao B; Ding M; Song S; Kang Y; Yu Y; Xu M; Xiang T; Gao L; Feng Q; Zhao Q; Zeng MS; Krummenacher C; Zeng YX
    Theranostics; 2020; 10(13):5704-5718. PubMed ID: 32483413
    [No Abstract]   [Full Text] [Related]  

  • 16. BALB/c mice immunized with a combination of virus-like particles incorporating Kaposi sarcoma-associated herpesvirus (KSHV) envelope glycoproteins gpK8.1, gB, and gH/gL induced comparable serum neutralizing antibody activity to UV-inactivated KSHV.
    Barasa AK; Ye P; Phelps M; Arivudainambi GT; Tison T; Ogembo JG
    Oncotarget; 2017 May; 8(21):34481-34497. PubMed ID: 28404899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization With Fc-Based Recombinant Epstein-Barr Virus gp350 Elicits Potent Neutralizing Humoral Immune Response in a BALB/c Mice Model.
    Zhao B; Zhang X; Krummenacher C; Song S; Gao L; Zhang H; Xu M; Feng L; Feng Q; Zeng M; Xu Y; Zeng Y
    Front Immunol; 2018; 9():932. PubMed ID: 29765376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The conserved disulfide bond within domain II of Epstein-Barr virus gH has divergent roles in membrane fusion with epithelial cells and B cells.
    Möhl BS; Sathiyamoorthy K; Jardetzky TS; Longnecker R
    J Virol; 2014 Dec; 88(23):13570-9. PubMed ID: 25231307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Neutralizing Antibody Targeting gH Provides Potent Protection against EBV Challenge
    Hong J; Zhong L; Zheng Q; Wu Q; Zha Z; Wei D; Chen H; Zhang W; Zhang S; Huang Y; Chen K; Chen J; Li S; Zeng MS; Zeng YX; Xia N; Zhang X; Xu M; Chen Y
    J Virol; 2022 Apr; 96(8):e0007522. PubMed ID: 35348362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Epstein-Barr virus (EBV) glycoprotein B cytoplasmic C-terminal tail domain regulates the energy requirement for EBV-induced membrane fusion.
    Chen J; Zhang X; Jardetzky TS; Longnecker R
    J Virol; 2014 Oct; 88(20):11686-95. PubMed ID: 25100836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.